Characteristic . | BCG-Japan . | BCG-Russia . |
---|---|---|
Included | 50% (8754/17 506) | 50% (8752/17 506) |
Maternal characteristics | ||
Mother has a BCG scar | 65% (5584/8621) | 63% (5486/8654) |
Maternal age, y, median (IQR) | 26 (21–30) | 26 (21–30) |
MUAC, mm, median (IQR) | 274 (252–300) | 272 (252–300) |
Supplied at least 1 telephone contact | 99.1% (8676/8754) | 99.3% (8690/8752) |
Family resides in BHP HDSS study area | 16% (1369/8754) | 16% (1361/8752) |
Maternal years of schooling, median (IQR) | 8 (4–11) | 7 (3–11) |
Neonate characteristics | ||
Cesarean delivery | 14% (1213/8742) | 13% (1169/8743) |
Admitted at hospital before inclusiona | 7.4% (639/8649) | 6.7% (582/8636) |
Low birth weight (<2500 g) | 17% (1452/8754) | 16% (1403/8752) |
Inclusion weight, g, median (IQR) | 2975 (2660–3295) | 2980 (2660–3300) |
Recruited on day of birth | 18% (1615/8754) | 19% (1673/8752) |
Age at inclusion, d, median (IQR) | 1 (1–1) | 1 (1–1) |
Male sex | 52% (4543/8754) | 52% (4521/8752) |
Twinning percentage | 5.0% (441/8754) | 4.6% (406/8752) |
Size of postvaccination wheal, mm, mean (SD) | 4.5 (0.5) | 4.5 (0.5) |
Characteristic . | BCG-Japan . | BCG-Russia . |
---|---|---|
Included | 50% (8754/17 506) | 50% (8752/17 506) |
Maternal characteristics | ||
Mother has a BCG scar | 65% (5584/8621) | 63% (5486/8654) |
Maternal age, y, median (IQR) | 26 (21–30) | 26 (21–30) |
MUAC, mm, median (IQR) | 274 (252–300) | 272 (252–300) |
Supplied at least 1 telephone contact | 99.1% (8676/8754) | 99.3% (8690/8752) |
Family resides in BHP HDSS study area | 16% (1369/8754) | 16% (1361/8752) |
Maternal years of schooling, median (IQR) | 8 (4–11) | 7 (3–11) |
Neonate characteristics | ||
Cesarean delivery | 14% (1213/8742) | 13% (1169/8743) |
Admitted at hospital before inclusiona | 7.4% (639/8649) | 6.7% (582/8636) |
Low birth weight (<2500 g) | 17% (1452/8754) | 16% (1403/8752) |
Inclusion weight, g, median (IQR) | 2975 (2660–3295) | 2980 (2660–3300) |
Recruited on day of birth | 18% (1615/8754) | 19% (1673/8752) |
Age at inclusion, d, median (IQR) | 1 (1–1) | 1 (1–1) |
Male sex | 52% (4543/8754) | 52% (4521/8752) |
Twinning percentage | 5.0% (441/8754) | 4.6% (406/8752) |
Size of postvaccination wheal, mm, mean (SD) | 4.5 (0.5) | 4.5 (0.5) |
Data are presented as % (no./No.) unless otherwise indicated.
Abbreviations: BCG, bacille Calmette-Guérin; BHP, Bandim Health Project; HDSS, Health and Demographic Surveillance System; IQR, interquartile range; MUAC, mid-upper arm circumference; SD, standard deviation.
aNewborns who were transferred to neonatal intensive care or the pediatric ward before they were discharged from the hospital and included in the trial.
Characteristic . | BCG-Japan . | BCG-Russia . |
---|---|---|
Included | 50% (8754/17 506) | 50% (8752/17 506) |
Maternal characteristics | ||
Mother has a BCG scar | 65% (5584/8621) | 63% (5486/8654) |
Maternal age, y, median (IQR) | 26 (21–30) | 26 (21–30) |
MUAC, mm, median (IQR) | 274 (252–300) | 272 (252–300) |
Supplied at least 1 telephone contact | 99.1% (8676/8754) | 99.3% (8690/8752) |
Family resides in BHP HDSS study area | 16% (1369/8754) | 16% (1361/8752) |
Maternal years of schooling, median (IQR) | 8 (4–11) | 7 (3–11) |
Neonate characteristics | ||
Cesarean delivery | 14% (1213/8742) | 13% (1169/8743) |
Admitted at hospital before inclusiona | 7.4% (639/8649) | 6.7% (582/8636) |
Low birth weight (<2500 g) | 17% (1452/8754) | 16% (1403/8752) |
Inclusion weight, g, median (IQR) | 2975 (2660–3295) | 2980 (2660–3300) |
Recruited on day of birth | 18% (1615/8754) | 19% (1673/8752) |
Age at inclusion, d, median (IQR) | 1 (1–1) | 1 (1–1) |
Male sex | 52% (4543/8754) | 52% (4521/8752) |
Twinning percentage | 5.0% (441/8754) | 4.6% (406/8752) |
Size of postvaccination wheal, mm, mean (SD) | 4.5 (0.5) | 4.5 (0.5) |
Characteristic . | BCG-Japan . | BCG-Russia . |
---|---|---|
Included | 50% (8754/17 506) | 50% (8752/17 506) |
Maternal characteristics | ||
Mother has a BCG scar | 65% (5584/8621) | 63% (5486/8654) |
Maternal age, y, median (IQR) | 26 (21–30) | 26 (21–30) |
MUAC, mm, median (IQR) | 274 (252–300) | 272 (252–300) |
Supplied at least 1 telephone contact | 99.1% (8676/8754) | 99.3% (8690/8752) |
Family resides in BHP HDSS study area | 16% (1369/8754) | 16% (1361/8752) |
Maternal years of schooling, median (IQR) | 8 (4–11) | 7 (3–11) |
Neonate characteristics | ||
Cesarean delivery | 14% (1213/8742) | 13% (1169/8743) |
Admitted at hospital before inclusiona | 7.4% (639/8649) | 6.7% (582/8636) |
Low birth weight (<2500 g) | 17% (1452/8754) | 16% (1403/8752) |
Inclusion weight, g, median (IQR) | 2975 (2660–3295) | 2980 (2660–3300) |
Recruited on day of birth | 18% (1615/8754) | 19% (1673/8752) |
Age at inclusion, d, median (IQR) | 1 (1–1) | 1 (1–1) |
Male sex | 52% (4543/8754) | 52% (4521/8752) |
Twinning percentage | 5.0% (441/8754) | 4.6% (406/8752) |
Size of postvaccination wheal, mm, mean (SD) | 4.5 (0.5) | 4.5 (0.5) |
Data are presented as % (no./No.) unless otherwise indicated.
Abbreviations: BCG, bacille Calmette-Guérin; BHP, Bandim Health Project; HDSS, Health and Demographic Surveillance System; IQR, interquartile range; MUAC, mid-upper arm circumference; SD, standard deviation.
aNewborns who were transferred to neonatal intensive care or the pediatric ward before they were discharged from the hospital and included in the trial.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.